Summary
This prediction ended on 02.03.18 with a price of €36.36. The BUY prediction by melinda finished with a performance of 9.15%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Shire plc | - | - | - | - |
iShares Core DAX® | -1.347% | 3.576% | 14.229% | 18.356% |
iShares Nasdaq 100 | 1.169% | 7.020% | 35.388% | 58.850% |
iShares Nikkei 225® | -0.327% | -0.673% | 8.618% | 6.718% |
iShares S&P 500 | 0.510% | 4.445% | 28.019% | 49.406% |
Comments by melinda for this prediction
In the thread Shire plc diskutieren
Biotechnologie und medizinische SecteurRecherche
Shire Pharmaceuticals Group
FDA akzeptiert die Anfrage Shire Lizenz für die biologische Behandlung von calaspargase Pegol (cal-PEG) gegen akute lymphoblastische Leukämie (ALL
(Zielkurs erreicht)